WebDisclosure WebDisclosure
Basculer en Français
8690 Companies
150098 Keywords
85680 Articles
80500 Press releases
Headlines Articles Press releases Center Point Bio-Tech Remove
  1. Home
  2. Companies
  3. Center Point Bio-Tech
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 01/25/2024 at 00:30, 1 year 4 months ago

    Center Point Bio-Tech's Launch of Novel Veterinary Diagnostic System Exceeds Expectations

    Center Point Bio-Tech successfully launches AlphaION, a revolutionary veterinary diagnostic system, at the 2024 Veterinary Meeting & Expo. Orders exceed expectations. AlphaION brings new testing options and automation to improve hospital workflow.
    Center Point Bio-Tech AlphaION Veterinary Diagnostic System Hospital Workflow Veterinary Medicine
Accesswire
  • Published on 05/28/2025 at 14:30, 2 hours 44 minutes ago

    Volcon ePowersports Obtains Floor Plan Program with Dealer Direct Financing

  • Published on 05/28/2025 at 14:30, 2 hours 44 minutes ago

    Aspire Biopharma Holdings, Inc., Provides Development Update on BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement, Expected to Launch in Third Quarter of 2025

  • Published on 05/28/2025 at 14:30, 2 hours 44 minutes ago

    MIRA Pharmaceuticals to Participate in BIO 2025 in Boston and Highlights Ongoing Progress Across Clinical Program

  • Published on 05/28/2025 at 13:56, 3 hours 18 minutes ago

    QNX Launches QNX Hypervisor 8.0 to Accelerate Embedded Software Development

  • Published on 05/28/2025 at 13:45, 3 hours 29 minutes ago

    Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value

View all ACCESSWIRE
EQS Group
  • Published on 05/28/2025 at 17:00, 13 minutes ago

    EQS-Adhoc: Biotest AG: Change of the Chief Executive Officer (CEO) of Biotest AG

  • Published on 05/28/2025 at 16:53, 20 minutes ago

    Leifheit AG: Annual General Meeting approves increased total dividend of EUR 1.20 per dividend-entitled share

  • Published on 05/28/2025 at 16:40, 34 minutes ago

    naoo AG: Shareholders Approve All Proposals at the 2025 Annual General Meeting

  • Published on 05/28/2025 at 16:19, 55 minutes ago

    EQS-Adhoc: FamiCord AG acquires majority stake in Národní Centrum Pupečníkové Krve and Rodinná banka perinatálnych a mezenchymálnych buniek

  • Published on 05/28/2025 at 15:40, 1 hour 34 minutes ago

    Cherry SE successfully completes sale of hygiene peripherals division

View all EQS
Les Echos
  • Published on 05/28/2025 at 11:23, 5 hours 51 minutes ago

    250528 BENETEAU Déclaration du nombre d'actions et de droits de vote au 30-04-2025

  • Published on 05/28/2025 at 08:00, 9 hours 14 minutes ago

    EURAZEO INVESTIT DANS 3P, ÉDITEUR DE LOGICIELS SPÉCIALISÉ DANS LES SOLUTIONS DE GESTION DES MARCHES PUBLICS ET DES ACHATS POUR LES INSTITUTIONS PUBLIQUES EN BELGIQUE ET EN FRANCE

  • Published on 05/28/2025 at 08:00, 9 hours 14 minutes ago

    EURAZEO TO INVEST IN 3P, A LEADING SOFTWARE PROVIDER OF PUBLIC PROCUREMENT AND POST PROCUREMENT SOLUTIONS IN BELGIUM AND FRANCE

  • Published on 05/27/2025 at 18:00, 23 hours 14 minutes ago

    Gimv sells Joolz to Bugaboo, creating the foundations for a global house of high-quality stroller brands

  • Published on 05/27/2025 at 18:00, 23 hours 14 minutes ago

    Gimv verkoopt Joolz aan Bugaboo en legt zo de basis voor een wereldwijd ‘house of brands’ van hoogwaardige kinderwagenmerken.

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy